In one paragraphArticle in Toxins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors at 2 institutions in 2 countries.
Francisco J R MejíasAllelopathy Group, Department of Organic Chemistry, Institute of Biomolecules (INBIO), Campus CEIA3, School of Science, University of Cádiz, C/República Saharaui, 7, 11510 Puerto Real, Spain.ORCID 0000-0001-6952-2964 Alexandra G DuránAllelopathy Group, Department of Organic Chemistry, Institute of Biomolecules (INBIO), Campus CEIA3, School of Science, University of Cádiz, C/República Saharaui, 7, 11510 Puerto Real, Spain.ORCID 0000-0002-9799-0850 Nuria ChinchillaAllelopathy Group, Department of Organic Chemistry, Institute of Biomolecules (INBIO), Campus CEIA3, School of Science, University of Cádiz, C/República Saharaui, 7, 11510 Puerto Real, Spain.ORCID 0000-0002-6659-373X Rosa M VarelaAllelopathy Group, Department of Organic Chemistry, Institute of Biomolecules (INBIO), Campus CEIA3, School of Science, University of Cádiz, C/República Saharaui, 7, 11510 Puerto Real, Spain.ORCID 0000-0003-3616-9134 José A ÁlvarezDepartment of Physical Chemistry, Faculty of Sciences, INBIO, University of Cádiz, 11510 Puerto Real, Spain.
José M G MolinilloAllelopathy Group, Department of Organic Chemistry, Institute of Biomolecules (INBIO), Campus CEIA3, School of Science, University of Cádiz, C/República Saharaui, 7, 11510 Puerto Real, Spain.ORCID 0000-0002-7844-9401 Francisco García-CozarDepartment of Biomedicine, Biotechnology and Public Health, University of Cádiz and Institute of Biomedical Research Cádiz (INIBICA), 11009 Cádiz, Spain.ORCID 0000-0003-3720-259X Francisco A MacíasAllelopathy Group, Department of Organic Chemistry, Institute of Biomolecules (INBIO), Campus CEIA3, School of Science, University of Cádiz, C/República Saharaui, 7, 11510 Puerto Real, Spain.ORCID 0000-0001-8862-2864 Universidad de Cádiz · ESUniversität Innsbruck · AT
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
In the work described here, a number of sesquiterpenes and benzoxazinoids from natural sources, along with their easily accessible derivatives, were evaluated against the main protease, RNA replicase and spike glycoprotein of SARS-CoV-2 by molecular docking. These natural products and their derivatives have previously shown remarkable antiviral activities. The most relevant compounds were the 4-fluoro derivatives of santamarine, reynosin and 2-amino-3
Indexed as
Biological ProductsCOVID-19SesquiterpenesAntiviral AgentsBenzoatesBenzoxazinesCoronavirus 3C ProteasesHumansHydrogenLigandsMolecular Docking SimulationMolecular Dynamics SimulationProtease InhibitorsRNA-Dependent RNA PolymeraseSARS-CoV-2Spike Glycoprotein, Coronavirus4-fluorobenzoic acidAntiviral AgentsBenzoatesBenzoxazinesBiological ProductsCoronavirus 3C ProteasesHydrogenLigandsProtease InhibitorsreynosinRNA-Dependent RNA PolymerasesantamarineSesquiterpenesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2benzoxazinoidCOVID-19dockingmolecular dynamicsSARS-CoV-2sesquiterpene
Identifiers
PMID36136537
PMCPMC9506577
OpenAlexW4293770695
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390